Rapha Capital PE Life Sciences Fund VI, LP
Raised
$1M
Investors
2
Min Invest
$250,000
AltStreet Analysis
·Generated from EDGAR primary sources
Rapha Capital PE Life Sciences Fund VI, LP is a Delaware limited partnership that filed an original Form D on 2023-02-08 under Rule 506(b). The fund raised $1.1M from 2 investors with a $250K minimum investment. Related persons include Kevin Slawin (Executive Officer, Promoter), Rapha Capital PE Life Sciences Fund GP, LLC (Promoter), and Rapha Capital Management, LLC (Promoter).
This is a private equity life sciences fund operating under the standard 506(b) exemption, which permits general solicitation restrictions. The $250K minimum investment positions it in the lower tier for institutional alternative investments, though the early-stage capital raise of $1.1M suggests an initial close or emerging fund launch.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Kevin Slawin
Executive Officer, Promoter · Surfside, FL
n/a Rapha Capital PE Life Sciences Fund GP, LLC
Promoter · Surfside, FL
n/a Rapha Capital Management, LLC
Promoter · Surfside, FL
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
